Minerva Surgical Inc
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally… Read more
Minerva Surgical Inc (UTRS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: -0.252x
Based on the latest financial reports, Minerva Surgical Inc (UTRS) has a cash flow conversion efficiency ratio of -0.252x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.09 Million) by net assets ($20.25 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Minerva Surgical Inc - Cash Flow Conversion Efficiency Trend (2019–2022)
This chart illustrates how Minerva Surgical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Minerva Surgical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Minerva Surgical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Botswana Diamonds plc
LSE:BOD
|
-0.001x |
|
Bunnys Limited
KAR:BNL
|
N/A |
|
DANNEX AYRTON STARWIN PLC
GSE:DASPHARMA
|
N/A |
|
Securities Trust of Scotland plc
LSE:STS
|
0.011x |
|
Crown Asia Chemicals Corp
PSE:CROWN
|
0.074x |
|
NAMIBIAN COPPER
BE:42N
|
N/A |
|
One Health Group Plc
LSE:OHGR
|
N/A |
|
Beacon Rise Holdings PLC
LSE:BRS
|
-0.001x |
Annual Cash Flow Conversion Efficiency for Minerva Surgical Inc (2019–2022)
The table below shows the annual cash flow conversion efficiency of Minerva Surgical Inc from 2019 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $17.18 Million | $-35.57 Million | -2.070x | -307.98% |
| 2021-12-31 | $44.10 Million | $-22.38 Million | -0.507x | -1019.45% |
| 2020-12-31 | $-221.81 Million | $-12.24 Million | 0.055x | -42.97% |
| 2019-12-31 | $-204.52 Million | $-19.79 Million | 0.097x | -- |